Respondents, n = 3156 | Nonrespondents, n = 548 | ||
---|---|---|---|
Included in Regression Analysis, n = 2776 | Excluded from Regression Analysis, n = 380 | ||
Women, % | 75 | 75 | 76 |
Age, yrs | 61 (51–69) | 68 (61–75)* | 65 (52–77)** |
Disease duration, yrs | 7 (3–15) | 8 (3–16) | 8 (3–16)** |
s-CRP, mg/1 | 9 (4–12) | 10 (5–16)* | 10 (5–16)** |
Swollen joint count | 0 (0–2) | 1 (0–2) | 1 (0–2) |
Tender joint count | 1 (0–4) | 1 (0–4) | 1 (0–4) |
Radiographic erosions, % | 63 | 70* | 69** |
IgM-rheumatoid factor-positive, % | 76 | 79 | 80 |
Biological therapy, % | 21 | 19 | 16** |
Use of methotrexate, % | 73 | 76 | 66** |
Glucocorticoid last month, % | 19 | 26* | 25** |